InnoCare Pharma Limited (INCPF)

PNK: INCPF · Real-Time Price · USD

3.26

0.00 (0.00%)

At close: Apr 30, 2025, 8:00 PM

InnoCare Pharma Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	6.22B	8.22B	8.7B	5.93B	3.97B	2.29B	1.88B	36.87M
Short-Term Investments	1.06B	-187	313.29M	317.06M	1.67B	80.35M	169.05M	10.02M
Long-Term Investments	-603.31M	5.66M	-301.58M	9.04M	1.16M	-79.19M	-167.9M	-8.86M
Other Long-Term Assets	1.08B	16.97M	326.38M	50.95M	1.16M	30.86M	1.33M	10.9M
Receivables	371.16M	276.38M	127.82M	45.27M	152K	37K	44K	n/a
Inventory	95.58M	119.09M	65.32M	9.92M	1.88M	7.62M	n/a	n/a
Other Current Assets	10.63M	10.39M	189.61M	116.14M	120.56M	36.59M	14.5M	5.84M
Total Current Assets	7.82B	8.77B	9.3B	6.42B	4.09B	2.41B	2.06B	53.58M
Property-Plant & Equipment	1.07B	1.09B	952.21M	502.37M	329.35M	58.42M	17.96M	12.08M
Goodwill & Intangibles	39.04M	42.13M	44.43M	142.57M	114.97M	116.5M	117.21M	39.7M
Total Long-Term Assets	1.59B	1.15B	1.02B	980.42M	445.48M	206.95M	137.66M	53.83M
Total Assets	9.41B	9.92B	10.32B	7.4B	4.54B	2.62B	2.2B	107.4M
Account Payables	128.36M	134.9M	118.6M	84.6M	5.52M	8.2M	2.19M	2.96M
Deferred Revenue	n/a	n/a	280.03M	6.83M	720.00	336.54K	n/a	n/a
Short-Term Debt	193.8M	1.25B	1.2B	-6.83M	-720	9.1M	59.28M	76.33M
Other Current Liabilities	69.79M	684.72M	522.91M	120.03M	41.89M	32.1M	534K	20.13M
Total Current Liabilities	1.06B	2.09B	2.08B	329.3M	104.45M	65.67M	72.29M	105.41M
Long-Term Debt	1.02B	26.3M	n/a	1.2B	1.15B	1.12B	957.27M	380.54M
Other Long-Term Liabilities	303.13M	574.48M	287.76M	161.3M	n/a	4.38B	2B	6.46M
Total Long-Term Liabilities	1.6B	644.43M	601.4M	1.41B	1.27B	5.5B	2.97B	394.06M
Total Liabilities	2.66B	2.74B	2.68B	1.74B	1.38B	5.56B	3.04B	499.46M
Total Debt	1.27B	1.35B	1.25B	1.27B	1.17B	1.14B	1.03B	136.41M
Common Stock	23K	23K	23K	19K	16K	4K	3K	3K
Retained Earnings	-5.49B	-5.05B	-4.42B	-3.56B	-3.47B	-3.11B	n/a	n/a
Comprehensive Income	n/a	n/a	263.73M	9.17B	-167.45M	101.01M	n/a	n/a
Shareholders Equity	6.73B	7.15B	7.6B	5.6B	3.1B	-3B	-904.3M	-392.06M
Total Investments	459.59M	5.66M	11.71M	326.1M	1.16M	1.16M	1.16M	1.16M